This drug can reduce breast cancer recurrence
September 27th, 2011 - 1:51 pm ICT by IANSLondon, Sep 27 (IANS) Zoledronic acid, a group of drugs, tried out on breast cancers among post-menopausal women has shown promising results.
Mainly used to treat osteoporosis, zoledronic acid is also given to cancer patients to protect against the effects of secondary bone cancer, such as pain and weakness in the bones.
Lab studies have suggested that zoledronic acid might also have direct anti-tumour effects and enhance other chemotherapy treatments.
Led by Robert Coleman, professor at the Weston Park Hospital in Sheffield, Britain, the drug trial recruited 3,360 patients with stage II/III breast cancer from 174 centres.
They were randomised to receive chemotherapy and/or endocrine therapy, with or without zoledronic acid, according to a Weston statement.
An interim analysis confirmed the overall survival rate was 85 percent compared to 79 percent for women who did not receive zoledronic acid.
“This is a small but significant increase,” Coleman explains. These findings were presented at the 2011 European Multidisciplinary Cancer Congress.
- Drug counters bone-damaging effects of breast cancer medication - Oct 10, 2011
- Bone drug may help fight breast cancer - Jun 03, 2010
- Osteoporosis drug may benefit patients with oral cancer - Dec 14, 2010
- Breast cancer survivors are at higher risk for hip fractures - Feb 03, 2011
- Breast cancer survivors 'more likely to fall' - Mar 05, 2011
- Soy intake lowers breast cancer recurrence in hormone-sensitive cancers - Oct 19, 2010
- Key culprit in breast cancer metastasis identified - Feb 17, 2011
- Bone drug may help prevent spread of early lung cancer - Feb 26, 2011
- Gene mutation ups blood-clot risk in women taking breast cancer treatment - Jun 17, 2010
- Gene test may bring safe chemotherapy - Mar 23, 2012
- Keep tab on osteoporosis pain-reliever: Experts (Oct 20 is World Osteoporosis Day) - Oct 19, 2011
- Postmenopausal women urged to increase yearly dental checkups - Mar 11, 2011
- Bone drug may help prevent breast cancer spread - May 17, 2008
- Taking tamoxifen to prevent breast cancer can save lives and cut medical costs - Mar 14, 2011
- Gene combinations linked to hip osteoporosis in postmenopausal women - Mar 30, 2011
Tags: breast cancer, breast cancer recurrence, breast cancers, cancer congress, cancer patients, chemotherapy, chemotherapy treatments, drugs, interim analysis, menopausal women, multidisciplinary, osteoporosis, promising results, robert coleman, secondary bone cancer, sheffield, survival rate, weston park, weston park hospital, zoledronic acid